These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29780514)

  • 21. Histidine-Rich Cationic Cell-Penetrating Peptides for Plasmid DNA and siRNA Delivery.
    Kichler A; Mason AJ; Marquette A; Bechinger B
    Methods Mol Biol; 2019; 1943():39-59. PubMed ID: 30838608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique arginine array improves cytosolic localization of hydrocarbon-stapled peptides.
    Quach K; LaRochelle J; Li XH; Rhoades E; Schepartz A
    Bioorg Med Chem; 2018 Mar; 26(6):1197-1202. PubMed ID: 29150077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PepFect6 Mediated SiRNA Delivery into Organotypic Cultures.
    Dash-Wagh S; Langel Ü; Ulfendahl M
    Methods Mol Biol; 2016; 1364():27-35. PubMed ID: 26472439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.
    Cantini L; Attaway CC; Butler B; Andino LM; Sokolosky ML; Jakymiw A
    PLoS One; 2013; 8(9):e73348. PubMed ID: 24019920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
    Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
    J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered Histidine-Rich Peptides Enhance Endosomal Escape for Antibody-Targeted Intracellular Delivery of Functional Proteins.
    Zhao Y; Jiang H; Yu J; Wang L; Du J
    Angew Chem Int Ed Engl; 2023 Sep; 62(38):e202304692. PubMed ID: 37283024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA.
    Yu Z; Zhang X; Pei X; Cao W; Ye J; Wang J; Sun L; Yu F; Wang J; Li N; Lee K; Barth S; Yang VC; He H
    Int J Pharm; 2021 Sep; 606():120940. PubMed ID: 34310959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and evaluation of a peptide-based siRNA delivery system in vitro.
    Chen B; Yoo K; Xu W; Pan R; Han XX; Chen P
    Drug Deliv Transl Res; 2017 Aug; 7(4):507-515. PubMed ID: 28349343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lauroylated Histidine-Enriched S4
    Morais CM; Cardoso AM; Aguiar L; Vale N; Nóbrega C; Zuzarte M; Gomes P; Pedroso de Lima MC; Jurado AS
    Pharm Res; 2020 Sep; 37(10):188. PubMed ID: 32888084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
    Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
    Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.
    Alexander-Bryant AA; Zhang H; Attaway CC; Pugh W; Eggart L; Sansevere RM; Andino LM; Dinh L; Cantini LP; Jakymiw A
    Oral Oncol; 2017 Sep; 72():123-131. PubMed ID: 28797448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.
    Lundberg P; El-Andaloussi S; Sütlü T; Johansson H; Langel U
    FASEB J; 2007 Sep; 21(11):2664-71. PubMed ID: 17463227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
    Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment.
    Zhang X; Qin B; Wang M; Feng J; Zhang C; Zhu C; He S; Liu H; Wang Y; Averick SE; Vo NTN; Huang L; Liu W; Wang Z
    Int J Nanomedicine; 2022; 17():953-967. PubMed ID: 35280336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
    Egorova AA; Maretina MA; Kiselev AV
    Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.